Abstract: Methods of treating gastrointestinal spasms are provided. For example, methods of treating gastrointestinal spasms are provided, such methods not requiring the use of systemic drugs that have shown to (i) provide slow relief, (ii) cause adverse side effects, (iii) limit activities, (iv) worsen existing gastrointestinal conditions, (v) be unrecommended in several gastrointestinal conditions that include gastrointestinal spasms, or (vi) be unrecommended in the absence of diarrhea.

Abstract: Methods of and compositions for producing and using plant-based materials are provided. The methods include using biopolymers or their synthetic equivalents combined with a stable source of reactive oxygen species that when applied to or combined with a separate source of oxido-reducing enzyme or catalyst will cause the formation of an activated biopolymer with increased protein binding affinity and microbial control activities.

Abstract: Methods of and compositions for producing and using plant-based materials are provided. The methods include using biopolymers or their synthetic equivalents combined with a stable source of reactive oxygen species that when applied to or combined with a separate source of oxido-reducing enzyme or catalyst will cause the formation of an activated biopolymer with increased protein binding affinity and microbial control activities.

Abstract: Methods of and compositions for producing and using plant-based materials are provided. The methods include using biopolymers or their synthetic equivalents combined with a stable source of reactive oxygen species that when applied to or combined with a separate source of oxido-reducing enzyme or catalyst will cause the formation of an activated biopolymer with increased protein binding affinity and microbial control activities.

Abstract: Methods of and compositions for producing and using plant-based materials are provided. The methods include using biopolymers or their synthetic equivalents combined with a stable source of reactive oxygen species that when applied to or combined with a separate source of oxido-reducing enzyme or catalyst will cause the formation of an activated biopolymer with increased protein binding affinity and microbial control activities.

Abstract: The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems taught here include a phenolic compound bound to a reactive oxygen species, wherein the phenolic compound and the reactive oxygen species react at a target area in the presence of an oxidoreductase enzyme.

Abstract: The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems taught here include a phenolic compound bound to a reactive oxygen species, wherein the phenolic compound and the reactive oxygen species react at a target area in the presence of an oxidoreductase enzyme.

Abstract: The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems taught here include a phenolic compound bound to a reactive oxygen species, wherein the phenolic compound and the reactive oxygen species react at a target area in the presence of an oxidoreductase enzyme.

Abstract: The teachings provided herein generally relate to site-activated binding systems that selectively increase the bioactivity of phenolic compounds at target sites. More particularly, the systems taught here include a phenolic compound bound to a reactive oxygen species, wherein the phenolic compound and the reactive oxygen species react at a target area in the presence of an oxidoreductase enzyme.

Abstract: The present invention is directed to a method and a composition for producing and using a plant-based biocidal solution. The plant-based biocidal solution contains a bioactive material and a plant-based substance formed from the cellular material of a plant. The plant-based substance is capable of binding to the bioactive material. In some embodiments, the bioactive material is hydrogen peroxide. The hydrogen peroxide can be added exogenously or generated endogenously. In accordance with further embodiments, the plant-based biocidal solution can be applied to a target, thereby impairing the target. In some embodiments, the target can be a pathogen. In accordance with another embodiment, the plant-based substance of the plant-based biocidal solution can form a microscopic cluster, a complex, or an aggregate for providing sufficient bioactive material to overcome the defense mechanism of the target.

Abstract: Methods of and compositions for producing and using plant-based materials are provided. The methods include using biopolymers or their synthetic equivalents combined with a stable source of reactive oxygen species that when applied to or combined with a separate source of oxido-reducing enzyme or catalyst will cause the formation of an activated biopolymer with increased protein binding affinity and microbial control activities.

Abstract: A method for processing blood samples in order to produce DNA complex patterns for diagnostic applications.

Abstract: A medication delivery device is disclosed having a hollow drill bit with a lateral opening that is adjacent to a beveled or sharpened tip of a hypodermic needle. The lateral opening, which can be a slot or a notch or hole, is located a distance proximal of the sharpened tip that is not less than the thickness of the tissue to be penetrated. This structure allows the hollow drill to penetrate bone and/or other hard tissues without being completely clogged by drilling debris. After drilling into the bone or hard tissue, medication can be delivered through the bore of the hollow drill. The lateral opening provides a clog-free passage for injection of the medication.

Abstract: A method for processing blood samples in order to produce DNA complex patterns for diagnostic applications. The method includes the aggregation and deposition of the DNA complex from the blood of a human being in order to form a unique pattern which can be used as a medical diagnostic tool to identify a change in the body caused by a specific physiological or pathological condition. The method identifies a change in the body by comparing the pattern of a person before a specific physiological or pathological condition to the pattern of a person after the condition. The specific condition causing the change is then determined by identifying and associating the unique pattern after the condition to the specific condition or disease based on comparative appearance. The present invention can be used as a diagnostic tool to aid in the determination of, among other things, the sex of a human fetus within a few days after conception, and the presence of a cancerous condition in the earliest stage of the disease.

Abstract: A medication delivery device is disclosed having a hollow drill bit with a lateral opening that is adjacent to a beveled or sharpened tip of a hypodermic needle. The lateral opening, which can be a slot or a notch or hole, is located a distance proximal of the sharpened tip that is not less than the thickness of the tissue to be penetrated. This structure allows the hollow drill to penetrate bone and/or other hard tissues without being completely clogged by drilling debris. After drilling into the bone or hard tissue, medication can be delivered through the bore of the hollow drill. The lateral opening provides a clog-free passage for injection of the medication.

Abstract: A method for the creation of stem cells substantially equivalent to the embryonic stem cells or embryonic germ cells, but without legal or ethical complications. The method is illustrated in the context of the creation of a totipoent cell equivalent to a human fertilized egg by total asexual process. The present method uses somatic cell nuclear transfer (SCNT) technology by which the nucleus of an egg from a mammalian, other than human, was removed with care to avoid significant disruption of the egg plasma. Then a human somatic cell (any body cell other than germ cells) is arranged side by side with the de-nucleated egg. The de-nucleated egg and the human somatic cell are fused by chemical induced cell fusion, and mitochondria are transferred from the nucleus donor to the de-nucleated animal egg. After the fusion, the newly formed chimeric cell may be properly stimulated to start development, or stored cryogenically for later use.

Abstract: A medication injection method and related device with a hollow drill bit for delivery of anesthetic or other medication through the hollow drill bit are disclosed. The device preferably includes a hollow drill bit, a disposable fluid dispenser, a handpiece, a handle, and a foot control pedal. The device can deliver anesthetic or other medication before, during and/or after drilling of a tooth or bone structure without removing the drill bit. The invention relates to an intraosseous and/or hard tissue drug delivery system that combines perforating and drug delivering functions in one device and one operation.

Abstract: An intraosseous and/or hard tissue drug delivery device and method is disclosed that perforates hard tissue and provides a drug delivery passage into underlying tissue. The device of the present invention includes a hollow drill bit and a stylet removably inserted into the hollow drill bit. The stylet keeps the bore of the hollow drill bit from plugging up during drilling. The stylet is removed after drilling to permit the operator to inject medication through the bore of the hollow drill bit.